You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ACRS Exercise Disclosure
Kolbeck Roland Wilhelm · SEC Form 4 · Filed Aug 4, 2026
Exercise
Calculated transaction value
$0
Kolbeck Roland Wilhelm Chief Scientific Officer
ACRS
Aclaris Therapeutics
ACRS
Transaction date
Aug 1, 2026
Public filing date
Aug 4, 2026
Filing lag
Filed 3 days later
ACRS daily price context
Close on/before transaction
$5.2
Jul 31, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Units on Common Stock
- Quantity / price
- 36,375 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0002076327-26-000006
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$64.4K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Aclaris Therapeutics, Inc. ACRS | Exercise | Aug 1, 2026 | Not reported |
| Aclaris Therapeutics, Inc. ACRS | Disposition | Aug 1, 2026 | $64.4K |
| Aclaris Therapeutics, Inc. ACRS Current | Exercise | Aug 1, 2026 | $0 |